Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoTHERa
NCT07220135Phase 2Recruiting
- Sponsor
- University of Kansas Medical Center
- Start
- Nov 2025
- Primary completion
- Nov 2027
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin in breast cancer, sponsored by University of Kansas Medical Center. Started Nov 2025; status: recruiting.
02
Drugs
carboplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07220135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07220135.